Advertisement

Ads Placeholder
Loading...

Lyka Labs Limited

LYKALABS.BOBSE
Healthcare
Biotechnology
55.05
3.77(7.35%)
Indian Market opens in 34h 47m

Lyka Labs Limited (LYKALABS.BO) Stock Overview

Explore Lyka Labs Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2B
P/E Ratio-303.27
EPS (TTM)$0.59
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$56.84
3 Months$21.55
1 Year Target$119.64

LYKALABS.BO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lyka Labs Limited (LYKALABS.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $119.64.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -303.27 and a market capitalization of 2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.35%
5-Day Change
7.37%
1-Month Change
-10.36%
3-Month Change
-32.68%
6-Month Change
-43.17%
Year-to-Date (YTD) Change
-28.66%
1-Year Change
-48.60%
3-Year Change
-48.43%
5-Year Change
92.48%
All-Time (Max) Change
153.69%

Contact Information

91 22 6611 2200
Spencer Building, Mumbai, NaN, 400036

Company Facts

4,230 Employees
IPO DateDec 5, 2001
CountryIN
Actively Trading

Frequently Asked Questions